Keywords: agouron, begins, phase, ii, testing, ag, clinical

Agouron Begins Phase II Testing of AG 337

Article | 03 April 1995

Print This

Clinical progress reported in a Phase I trial of Agouron Pharmaceuticals' anticancer drug AG 337 has stimulated the company to enter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in